retatrutide lek for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Kup Retatrutide 20 mg ST

2023;135:190-201

Here's what researchers found.

Recent Findings GLP-1 agonists may be associated with breast changes and symptoms that warrant further breast imaging, including supplemental screening and/or for problem solving in the appropriate clinical scenario

Discover what clinical research reveals about joint discomfort during Ozempic, Wegovy, or Rybelsus treatment, potential causes, and when to seek medical evaluation.

Nevertheless, the certainty of the effect size following the GRADE classification was very low. Conclusions In this systematic review and meta-analysis, we found that GLP-1 RAs significantly prolonged gastric emptying T by a mean of 74min, which could have implications for perioperative care

Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D